P. Everett

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

C. Paweletz, A. Egloff, R. Tishler, 2021, Clinical Cancer Research.

Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC

M. M. Qureshi, K. Mak, Kei Suzuki, 2020, JTO clinical and research reports.

Preclinical assessment of curcumin as a potential therapy for B‐CLL

J. Meyers, A. Lerner, P. Everett, 2007, American journal of hematology.

Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2

C. Clish, V. Sukhatme, P. Seth, 2010, PloS one.

Optimal sequencing of chemoradiotherapy for locally advanced laryngeal cancer

G. Grillone, M. Dyer, M. M. Qureshi, 2019, The Laryngoscope.

Gamma heavy chain disease in a patient with underlying lymphoplasmacytic lymphoma of the thyroid. Report of a case and comparison with other reported cases with thyroid involvement.

C. O'Hara, M. Kroll, Josenia N M Tan, 2012, Clinica chimica acta; international journal of clinical chemistry.

Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis

W. Ezzat, M. M. Qureshi, M. Truong, 2018, Head & neck.

Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

P. Everett, Claire E P Smith, Jessica Freydman, 2021, The Annals of pharmacotherapy.

Change in stage after neoadjuvant chemoradiation is associated with survival in patients with esophageal cancer.

M. M. Qureshi, V. Litle, M. Truong, 2023, Journal of surgical oncology.